NIH clinical trial evaluating mixed COVID-19 vaccine schedules begins
Trial to evaluate safety, immunogenicity of various vaccine booster regimens.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Clinical Trials | COVID-19 | National Institutes of Health (NIH) | Vaccines